Key result
AF genetic testing offers perceived value for patients understanding familial risk despite low ~20% yield.
Why the study?
Although genetic variation can affect susceptibility to AF, there is a lack of understanding of consumer interest in being tested and the value placed on genomic information.
What is the perceived value of genetic testing for atrial fibrillation among patients and their families?
What is the perceived value of genetic testing for atrial fibrillation among patients and their families?
This study aims to investigate consumer interest and the perceived value of genetic testing for atrial fibrillation.
Answers are grounded in this paper and cite their sources.
Patient views should shape AF genetic testing services; leaves open its value in improving clinical management.
There is accumulating evidence that genetic variation can cause or affect susceptibility to atrial fibrillation (AF) [1]. Although this argues for incorporation of genetic testing into clinical management, there is a lack of understanding of consumer interest in being tested and the value placed on genomic information about AF. Accordingly, this study aimed to investigate the perceived value of genetic testing for AF.
No takes yet. Share an insight, caveat, or question.
Fehlberg et al. (2026) studied Australian adults aged 18 years or older with lived experience of atrial fibrillation or family members with atrial fibrillation (n=14). Genetic testing for high-risk atrial fibrillation-related genes was evaluated on Perceived value of genetic testing for atrial fibrillation assessed by qualitative focus group discussions. Participants valued genetic testing for atrial fibrillation to better understand personal and familial risk and hoped it would improve clinical management, despite low current yield of positive genetic results.
Synapse has enriched 10 related papers. Consider them for comparative context: